Total and Poly(A)+RNA
Collections of RNA isolated from:
|
Blood cells
isolation/activation and RNA purification procedures Quality Control data obtained with glyoxal electrophoresis and Agilent 2100 Bioanalyzer |
RNA isolated from normal and activated human leukocytes:
|
Name |
Human blood cells |
Total RNA |
Cat.# |
Price |
|
TL |
Total Leukocytes |
10 µg |
N1101 |
£200 |
|
50 µg |
N1102 |
£600 |
||
|
MN |
Mononuclear Cells: B-Lymphocytes, T-Lymphocytes, Monocytes |
10 µg |
N1106 |
£200 |
|
50 µg |
N1107 |
£600 |
||
|
MN-A |
Activated Mononuclear Cells |
10 µg |
N1111 |
£200 |
|
50 µg |
N1112 |
£600 |
||
|
CD14 |
Monocytes (CD14-positive) |
10 µg |
N1116 |
£250 |
|
50 µg |
N1117 |
£900 |
||
|
CD4 |
T-Helper / Inducer Lymphocytes (CD4-positive) |
10 µg |
N1121 |
£350 |
|
50 µg |
N1122 |
£1250 |
||
|
CD4-A |
Activated T-Helper / Inducer Lymphocytes |
10 µg |
N1126 |
£250 |
|
50 µg |
N1127 |
£900 |
||
|
CD8 |
T-Supressor / Cytotoxic Lymphocytes (CD8-positive) |
10 µg |
N1131 |
£380 |
|
50 µg |
N1132 |
£1250 |
||
|
CD8-A |
Activated T-Supressor / Cytotoxic Lymphocytes |
10 µg |
N1136 |
£250 |
|
50 µg |
N1137 |
£900 |
||
|
CD19 |
B-Lymphocytes (CD19-positive) |
10 µg |
N1141 |
£600 |
|
50 µg |
N1142 |
£2100 |
||
|
CD19-A |
Activated B-Lymphocytes |
10 µg |
N1146 |
£400 |
|
50 µg |
N1147 |
£1500 |
All RNA preparations are also available in pack size of 1 mg.
| Properties of pooled leukocytes | |||||
|
MN cells ( B- and T-lymphocytes and monocytes): pooled from 12 male \ female Caucasians aged 24-51 CD14+ ( monocytes ): pooled from 36 male \ female Caucasians aged 25-54 CD4+ ( T helper \ inducer cells ): pooled from 20 male \ female Caucasians aged 25-50 CD8+ ( T supressor \ cytotoxic ): pooled from 33 male \ female Caucasians aged 24-51
|
CD19+ ( B-lymphocytes ): pooled from 34 male \ female Caucasians aged 24-54 MN-activated cells: pooled from 4 male \ female Caucasians aged 38-54 CD4+ - activated cells: pooled from 12 male \ female Caucasians aged 24-49 CD8+ - activated cells: pooled from 8 male \ female Caucasians aged 22-48 CD19+ - activated cells: pooled from 4 male Caucasians aged 18-53
|
||||
RNA isolated from human tumor cell lines:
|
Name |
Human cell lines |
ATCC number |
Total RNA |
|
|
Cat.# |
Price per 100µg |
|||
|
A-549 |
Lung Carcinoma |
CCL-185 |
N2101 |
£200 |
|
BT-474 |
Breast Carcinoma |
HTB-20 |
N2106 |
£200 |
|
CaCo-2 |
Colorectal Adenocarcinoma |
HTB-37 |
N2111 |
£200 |
|
Daudi |
Burkitt's Lymphoma |
CCL-213 |
N2116 |
£200 |
|
G-361 |
Malignant Melanoma |
CRL-1424 |
N2121 |
£300 |
|
HBL-100 |
Breast Carcinoma |
HTB-124 |
N2126 |
£200 |
|
HeLa |
Cervix Adenocarcinoma |
CCL-2 |
N2131 |
£300 |
|
Hep G2 |
Hepatocellular Carcinoma |
HB-8065 |
N2136 |
£300 |
|
HL-60 |
Acute Promyelocytic Leukemia |
CCL-240 |
N2141 |
£200 |
|
JAR |
Choriocarcinoma |
HTB-144 |
N2146 |
£200 |
|
Jurkat |
Acute T Cell Leukemia |
TIB-152 |
N2151 |
£200 |
|
K-562 |
Chronic Myelogenous Leukemia |
CCL-243 |
N2156 |
£200 |
|
MCF7 |
Breast Adenocarcinoma |
HTB-22 |
N2161 |
£200 |
|
MOLT-4 |
Acute Lymphoblastic Leukemia |
CRL-1582 |
N2166 |
£200 |
|
NIH:OVCAR-3 |
Ovarian Adenocarcinoma |
HTB-161 |
N2171 |
£300 |
|
Raji |
Burkitt's Lymphoma |
CCL-86 |
N2176 |
£200 |
|
SW480 |
Colorectal Adenocarcinoma |
CCL-228 |
N2181 |
£200 |
|
UM-UC-3 |
Bladder Transitional Cell Carcinoma |
CRL-1749 |
N2186 |
£300 |
|
U-937 |
Histiocytic Lymphoma |
CRL-1593.2 |
N2191 |
£200 |
|
ZR-75-1 |
Breast Carcinoma |
CRL-1500 |
N2196 |
£300 |
|
5637 |
Bladder Carcinoma |
HTB-9 |
N3101 |
£300 |
Total and PolyA+ RNA isolated from human tissues
|
Tissue |
Source |
Total RNA |
||
|
Size |
Cat.# |
Price |
||
|
total brain |
human adult |
50 µg |
N5101 |
£200 |
|
250 µg |
N5102 |
£600 |
||
| human fetal |
50 µg |
N5106 |
£200 |
|
|
250 µg |
N5107 |
£600 |
||
| kidney | human adult |
50 µg |
N5111 |
£200 |
|
250 µg |
N5112 |
£600 |
||
| human fetal |
50 µg |
N5116 |
£200 |
|
|
250 µg |
N5117 |
£600 |
||
| lung | human adult |
50 µg |
N5121 |
£200 |
|
250 µg |
N5122 |
£600 |
||
| human fetal |
50 µg |
N5126 |
£200 |
|
|
250 µg |
N5127 |
£600 |
||
| liver | human adult |
50 µg |
N5131 |
£200 |
|
250 µg |
N5132 |
£600 |
||
| human fetal |
50 µg |
N5136 |
£200 |
|
|
250 µg |
N5137 |
£600 |
||
| spleen | human adult |
50 µg |
N5141 |
£200 |
|
250 µg |
N5142 |
£600 |
||
| human fetal |
50 µg |
N5146 |
£200 |
|
|
250 µg |
N5147 |
£600 |
||
| colon | human adult |
50 µg |
N5151 |
£200 |
|
250 µg |
N5152 |
£600 |
||
| adrenal gland | human fetal |
50 µg |
N5156 |
£200 |
|
250 µg |
N5157 |
£600 |
||
| heart | human fetal |
50 µg |
N5161 |
£200 |
|
250 µg |
N5162 |
£600 |
||
| small intestine | human fetal |
50 µg |
N5166 |
£200 |
|
250 µg |
N5167 |
£600 |
||
| skeletal muscle | human fetal |
50 µg |
N5171 |
£200 |
|
250 µg |
N5172 |
£600 |
||
| spinal cord | human fetal |
50 µg |
N5176 |
£200 |
|
250 µg |
N5177 |
£600 |
||
| stomach | human fetal |
50 µg |
N5181 |
£200 |
|
250 µg |
N5182 |
£600 |
||
| thymus | human fetal |
50 µg |
N5186 |
£200 |
|
250 µg |
N5187 |
£600 |
||
RNA isolated from mouse normal and tumor cell lines:
|
Name |
Mouse cell lines |
ATCC number |
Total RNA |
|
|
Cat.# |
Price per 100µg |
|||
|
Hepa-1c1c7 |
Hepatoma |
CRL-2026 |
N4101 |
£200 |
|
K-BALB (K-234) |
Embryonal Fibroblasts |
CCL-163.3 |
N4106 |
£200 |
|
L1210 |
Lymphocytic Leukemia |
CCL-219 |
N4111 |
£200 |
|
L-M |
Normal Subcutaneous Connective Tissue |
CCL-1.2 |
N4116 |
£200 |
|
M-MSV-BALB/3T3 |
Embryonal Fibroblasts |
CCL-163.2 |
N4121 |
£200 |
|
NB41A3 |
Neuroblastoma |
CCL-147 |
N4126 |
£200 |
|
P19 |
Teratocarcinoma |
CRL-1825 |
N4131 |
£200 |
|
P388D1 |
Lymphoma |
CCL-46 |
N4136 |
£200 |
|
P815 |
Mastocytoma |
TIB-64 |
N4141 |
£200 |
|
R1.1 |
Lymphoma |
TIB-42 |
N4146 |
£200 |
|
RAW 264.7 |
Abelson Murine Leukemia Virus-Induced Tumor |
TIB-71 |
N4151 |
£200 |
|
Sp2/0-Ag14 |
Hybridoma |
CRL-1581 |
N4156 |
£200 |
|
PU5-1.8 |
Lymphoid Tumor |
TIB-61 |
N4161 |
£200 |